Graft versus host disease affects roughly 40%-60% of patients who undergo haematopoietic stem cell transplant, with a mortality rate of 15%. In rare cases, this can progress to sclerodermatous graft versus host disease, with devastating associated morbidity and mortality. In this article, a patient shares their first-hand experience of living with the disease.
© 2024 The Author(s). Skin Health and Disease published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.